Lately, our co-founder Jess has been talking about perimenopause constantly — not in a vague, “I feel off” way, but in a “why am I exhausted, wired, irritated, wide awake and drenched at 3 a.m.” kind of way. The experience is disorienting in a very specific sense: you don’t feel like yourself, and no one has given you a clear explanation for why.
Perimenopause is no longer a whisper network topic. It's a clinical, economic, and productivity issue hiding in plain sight.
In Canada, this is not marginal. More than 10 million women are in perimenopause or menopause today, according to Statistics Canada. Up to 80% will experience symptoms that affect sleep, cognition, mood, and energy, and nearly one in three have considered stepping back from work because of it, yet fewer than half feel informed before it begins (Society of Obstetricians and Gynaecologists of Canada).
The symptom load is both broad and poorly recognized. While hot flashes get the airtime, this phase can involve more than 50 symptoms, from brain fog and anxiety to joint pain, vertigo, and skin sensations that make no intuitive sense. These are not edge cases. They're standard, driven by hormonal volatility, not personal decline.
Clinically, it's still under-identified. Women are often treated symptom-by-symptom — sleep, mood, weight, pain — across multiple providers, with no one connecting the dots.
And this is happening at a specific moment: women in their late 30s and 40s are often at peak earning power, peak leadership responsibility, and peak caregiving load, while navigating hormonal shifts that can destabilize sleep, cognition, mood, metabolism, and cardiovascular risk.
In response, a new layer of care is emerging, one that treats perimenopause as a distinct, complex phase requiring actual expertise.
The result: a rise in specialized clinics, hormone-literate physicians, and integrative care models designed specifically for midlife women.
This isn't generalized care. It's focused hormonal strategy, structured around time, context, and a fully integrative view of midlife women’s health. Within a private-pay model, these practices operate with greater clinical latitude, incorporating nonconventional and emerging menopause treatments into a more holistic standard of care.
We spoke with Dr. Cara Flamer, a Toronto-based physician specializing in perimenopause and menopause, about how she approaches this phase. The good news: you're not crazy.
BFT: What, exactly, is perimenopause?
Perimenopause is the transitional phase leading up to menopause, when hormone levels — particularly estrogen and progesterone — begin to fluctuate rather than decline smoothly. It typically starts in a woman’s 40s (sometimes earlier) and can last several years before periods stop completely.
BFT: How much peri/menopause training do physicians get in medschool?
I can only comment on my own training, which was many years ago! There was a little bit of training on menopause and medical management of menopausal symptoms. After I graduated, I learned a lot more, specifically relating to approaching this transition more holistically and using treatments other than/in addition to conventional medications.
BFT: What are women getting wrong about perimenopause?
You are not ‘going crazy.’ Perimenopause is a complex biological transition that affects both emotional and physical wellbeing. Many women feel disconnected from themselves during this time, but these changes are real, valid, and deeply physiological.
BFT: Does a one-time blood test have limitations?
Definitely. Hormone levels can change during the cycle. Also, if you are using hormones, the levels will be affected by when you took/applied your HRT. I find it helpful to look at the trend over time rather than one level in time.
BFT: What is your process when assessing a new patient?
The first appointment allows me to get to know their symptoms and health challenges, their history and their goals. I order bloodwork and often a dried urine test to assess a variety of things, including their hormone levels.
BFT: Why are many practitioners hesitant to give estrogen to patients who are suffering?
I think there is a lot of confusion about estrogen because of previous studies and conclusions that were drawn. There was a fear that estrogen caused breast cancer. After a re-examination of the data, it has been concluded that estrogen is not associated with breast cancer. I think sometimes old beliefs can be hard to let go of.
Also, not every doctor is up to date on the latest menopause and hormone therapy research—which is understandable, especially for busy family physicians responsible for a wide range of patient needs.
BFT: How can women think differently about this phase?
When viewed holistically, this stage can become an invitation to realign with yourself — to reassess priorities, welcome support, and learn new ways to care for your body and mind. Rather than something to simply endure, it can be a powerful stepping stone toward a more authentic and energized version of yourself.
BFT: What does that actually require on a day-to-day level?
Give yourself permission to make different choices. Adjustments in nutrition, sleep, movement, stress management, and personal boundaries can significantly reduce physiological stress and improve symptoms. Listening to your changing needs — and responding with compassion rather than pressure — can help restore balance and support overall wellbeing.
BFT: Where does medical support — and specifically hormones — fit into that picture?
You do not have to navigate this transition alone. Consider consulting a knowledgeable practitioner who creates space for honest, evidence-informed conversation about your symptoms and treatment options, including hormone therapy when appropriate. The right support can help you feel empowered, understood, and confident in your choices.
Strategic Edge
- Dedicated focus on perimenopause and menopause
- Extended consultation structure
- Evidence-based hormone therapy planning
- Whole-system lens: sleep, cognition, metabolic shifts, mood
- Private-pay model allows for access to nonconventional treatments for menopause
Capital Insight
Independent specialty practices trade patient volume for precision and retention. Fewer visits, higher trust, stronger lifetime patient value.
Forward Signal
Expect more physicians to carve out menopause-focused niches as demand for hormone-informed care accelerates.
The BFT Take
Perimenopause is not a niche health issue. It is a mass-market, midlife infrastructure gap hiding inside women’s bodies.
The system wasn’t designed for this phase — not at the level of time, continuity, or complexity it requires. So women compensate. They push through symptoms, misattribute declines in performance, or quietly recalibrate their lives without clinical support.
What practices like Dr. Flamer’s signal is a shift: from reactive care to strategic care. From volume to depth. From symptom management to system management.
And where the system leaves ambiguity, the market builds clarity.
Midlife women’s health is not just a clinical category. It’s an emerging sector — one where trust, time, and outcomes will define the next generation of care.
0 comments